Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection

Cytokine and Growth Factor Reviews

Volumn 25, Issue 2, 2014, Pages 91-106

  Clouthier, Derek L ^a   Watts, Tania H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Co stimulation; GITR; GITRL; T cell; TNFR

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; TNFRSF18 PROTEIN, HUMAN; TNFSF18 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ALLERGY; AUTOIMMUNITY; B LYMPHOCYTE; CANCER GROWTH; CELL STIMULATION; CHROMOSOMAL LOCALIZATION; COLITIS; DENDRITIC CELL; HUMAN; IN VITRO STUDY; INFECTION; INFLAMMATION; INTRACELLULAR SIGNALING; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MOLECULARLY TARGETED THERAPY; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; TISSUE TRANSPLANTATION; TUMOR ESCAPE; TUMOR IMMUNITY; ANIMAL; BIOSYNTHESIS; CELL ADHESION; COMMUNICABLE DISEASE; IMMUNOLOGY; MOUSE;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CELL ADHESION; COMMUNICABLE DISEASES; DENDRITIC CELLS; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; HUMANS; INFLAMMATION; MICE; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTORS;

EID: 84899050190     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2013.12.003     Document Type: Review

References (174)

1. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annual Review of Immunology 2005, 23:23-68.
2. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nature Reviews Immunology 2009, 9:271-285.
3. Zhu Y., Yao S., Chen L. Cell surface signaling molecules in the control of immune responses: a tide model. Immunity 2011, 34:466-478.
4. Nocentini G., Giunchi L., Ronchetti S., Krausz L.T., Bartoli A., Moraca R., et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:6216-6221.
5. Kwon B., Yu K.Y., Ni J., Yu G.L., Jang I.K., Kim Y.J., et al. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. Journal of Biological Chemistry 1999, 274:6056-6061.
6. Gurney A.L., Marsters S.A., Huang R.M., Pitti R.M., Mark D.T., Baldwin D.T., et al. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Current Biology: CB 1999, 9:215-218.
7. Kim J.D., Choi B.K., Bae J.S., Lee U.H., Han I.S., Lee H.W., et al. Cloning and characterization of GITR ligand. Genes and Immunity 2003, 4:564-569.
8. Tone M., Tone Y., Adams E., Yates S.F., Frewin M.R., Cobbold S.P., et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:15059-15064.
9. Nocentini G., Ronchetti S., Bartoli A., Spinicelli S., Delfino D., Brunetti L., et al. Identification of three novel mRNA splice variants of GITR. Cell Death and Differentiation 2000, 7:408-410.
10. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunology 2002, 3:135-142.
11. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., Collins M., et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002, 16:311-323.
12. Stephens G.L., McHugh R.S., Whitters M.J., Young D.A., Luxenberg D., Carreno B.M., et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+T cells. Journal of Immunology 2004, 173:5008-5020.
13. Suvas S., Kim B., Sarangi P.P., Tone M., Waldmann H., Rouse B.T. In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. Journal of Virology 2005, 79:11935-11942.
14. Krausz L.T., Bianchini R., Ronchetti S., Fettucciari K., Nocentini G., Riccardi C. GITR-GITRL system, a novel player in shock and inflammation. Scientific World Journal 2007, 7:533-566.
15. Zhan Y., Funda D.P., Every A.L., Fundova P., Purton J.F., Liddicoat D.R., et al. TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death. International Immunology 2004, 16:1315-1321.
16. Chen X., Murakami T., Oppenheim J.J., Howard O.M. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. European Journal of Immunology 2004, 34:859-869.
17. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+T regulatory cells. Nature Immunology 2003, 4:337-342.
18. Zhan Y., Gerondakis S., Coghill E., Bourges D., Xu Y., Brady J.L., et al. Glucocorticoid-induced TNF receptor expression by T cells is reciprocally regulated by NF-kappaB and NFAT. Journal of Immunology 2008, 181:5405-5413.
19. Nocentini G., Bartoli A., Ronchetti S., Giunchi L., Cupelli A., Delfino D., et al. Gene structure and chromosomal assignment of mouse GITR, a member of the tumor necrosis factor/nerve growth factor receptor family. DNA and Cell Biology 2000, 19:205-217.
20. Chattopadhyay S., Chakraborty N.G. GITR expression on T-cell receptor-stimulated human CD8 T cell in a JNK-dependent pathway. Indian Journal of Human Genetics 2009, 15:121-124.
21. Kohm A.P., Podojil J.R., Williams J.S., McMahon J.S., Miller S.D. CD28 regulates glucocorticoid-induced TNF receptor family-related gene expression on CD4+ T cells via IL-2-dependent mechanisms. Cellular Immunology 2005, 235:56-64.
22. Snell L.M., Lin G.H., Watts T.H. IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15. Journal of Immunology 2012, 188:5915-5923.
23. Snell L.M., Lin G.H., McPherson A.J., Moraes T.J., Watts T.H. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy. Immunological Reviews 2011, 244:197-217.
24. Esparza E.M., Arch R.H. Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation. Journal of Immunology 2005, 174:7869-7874.
25. Riccardi C., Cifone M.G., Migliorati G. Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: role of GITR and GILZ, two dexamethasone-induced genes. Cell Death and Differentiation 1999, 6:1182-1189.
26. Xie P. TRAF molecules in cell signaling and in human diseases. Journal of Molecular Signaling 2013, 8:7.
27. Snell L.M., McPherson A.J., Lin G.H., Sakaguchi S., Pandolfi P.P., Riccardi C., et al. CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection. Journal of Immunology 2010, 185:7223-7234.
28. Esparza E.M., Lindsten T., Stockhausen J.M., Arch R.H. Tumor necrosis factor receptor (TNFR)-associated factor 5 is a critical intermediate of costimulatory signaling pathways triggered by glucocorticoid-induced TNFR in T cells. Journal of Biological Chemistry 2006, 281:8559-8564.
29. Hauer J., Puschner S., Ramakrishnan P., Simon U., Bongers M., Federle C., et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:2874-2879.
30. Joetham A., Ohnishi H., Okamoto M., Takeda K., Schedel M., Domenico J., et al. Loss of T regulatory cell suppression following signaling through glucocorticoid-induced tumor necrosis receptor (GITR) is dependent on c-Jun N-terminal kinase activation. Journal of Biological Chemistry 2012, 287:17100-17108.
31. Cragg M.S., Walshe C.A., Ivanov A.O., Glennie M.J. The biology of CD20 and its potential as a target for mAb therapy. Current Directions in Autoimmunity 2005, 8:140-174.
32. Howie D., Nolan K.F., Daley S., Butterfield E., Adams E., Garcia-Rueda H., et al. MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation. Journal of Immunology 2009, 183:4197-4204.
33. Ronchetti S., Nocentini G., Riccardi C., Pandolfi P.P. Role of GITR in activation response of T lymphocytes. Blood 2002, 100:350-352.
34. Spinicelli S., Nocentini G., Ronchetti S., Krausz L.T., Bianchini R., Riccardi C. GITR interacts with the pro-apoptotic protein Siva and induces apoptosis. Cell Death and Differentiation 2002, 9:1382-1384.
35. Prasad K.V., Ao Z., Yoon Y., Wu M.X., Rizk M., Jacquot S., et al. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:6346-6351.
36. Py B., Slomianny C., Auberger P., Petit P.X., Benichou S. Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. Journal of Immunology 2004, 172:4008-4017.
37. Xue L., Chu F., Cheng Y., Sun X., Borthakur A., Ramarao M., et al. Siva-1 binds to and inhibits BCL-X(L)-mediated protection against UV radiation-induced apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:6925-6930.
38. Bossen C., Ingold K., Tardivel A., Bodmer J.L., Gaide O., Hertig S., et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. Journal of Biological Chemistry 2006, 281:13964-13971.
39. Chattopadhyay K., Ramagopal U.A., Mukhopadhaya A., Malashkevich V.N., Dilorenzo T.P., Brenowitz M., et al. Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: implications for function. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:19452-19457.
40. Zhou Z., Song X., Berezov A., Zhang G., Li Y., Zhang H., et al. Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:5465-5470.
41. Chattopadhyay K., Lazar-Molnar E., Yan Q., Rubinstein R., Zhan C., Vigdorovich V., et al. Sequence, structure, function, immunity: structural genomics of costimulation. Immunological Reviews 2009, 229:356-386.
42. Stone G.W., Barzee S., Snarsky V., Kee K., Spina C.A., Yu X.F., et al. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. Journal of Virology 2006, 80:1762-1772.
43. Kanagavelu S.K., Snarsky V., Termini J.M., Gupta S., Barzee S., Wright J.A., et al. Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine. Vaccine 2012, 30:691-702.
44. Cui D., Wang S., Chen Y., Tong J., Ma J., Tang L., et al. An isoleucine-zipper motif enhances costimulation of human soluble trimeric GITR ligand. Cellular & Molecular Immunology 2010, 7:316-322.
45. Chattopadhyay K., Ramagopal U.A., Brenowitz M., Nathenson S.G., Almo S.C. Evolution of GITRL immune function: murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:635-640.
46. Chattopadhyay K., Ramagopal U.A., Nathenson S.G., Almo S.C. 1.8 A structure of murine GITR ligand dimer expressed in Drosophila melanogaster S2 cells. Acta Crystallographica, Section D: Biological Crystallography 2009, 65:434-439.
47. Zhou Z., Tone Y., Song X., Furuuchi K., Lear J.D., Waldmann H., et al. Structural basis for ligand-mediated mouse GITR activation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:641-645.
48. Kim W.J., Bae E.M., Kang Y.J., Bae H.U., Hong S.H., Lee J.Y., et al. Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 2006, 119:421-429.
49. Bae E., Kim W.J., Kang Y.M., Suk K., Koh E.M., Cha H.S., et al. Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis. Clinical and Experimental Immunology 2007, 148:410-418.
50. Shin H.H., Kwon B.S., Choi H.S. Recombinant glucocorticoid induced tumour necrosis factor receptor (rGITR) induced COX-2 activity in murine macrophage Raw 264.7 cells. Cytokine 2002, 19:187-192.
51. Shin H.H., Lee M.H., Kim S.G., Lee Y.H., Kwon B.S., Choi H.S. Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induces NOS in murine macrophage. FEBS Letters 2002, 514:275-280.
52. Shin H.H., Lee H.W., Choi H.S. Induction of nitric oxide synthase (NOS) by soluble glucocorticoid induced tumor necrosis factor receptor (sGITR) is modulated by IFN-gamma in murine macrophage. Experimental & Molecular Medicine 2003, 35:175-180.
53. Lee H.S., Shin H.H., Kwon B.S., Choi H.S. Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) increased MMP-9 activity in murine macrophage. Journal of Cellular Biochemistry 2003, 88:1048-1056.
54. Bae E.M., Kim W.J., Suk K., Kang Y.M., Park J.E., Kim W.Y., et al. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Molecular Immunology 2008, 45:523-533.
55. Hwang H., Lee S., Lee W.H., Lee H.J., Suk K. Stimulation of glucocorticoid-induced tumor necrosis factor receptor family-related protein ligand (GITRL) induces inflammatory activation of microglia in culture. Journal of Neuroscience Research 2010, 88:2188-2196.
56. Lacal P.M., Petrillo M.G., Ruffini F., Muzi A., Bianchini R., Ronchetti S., et al. Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion. Journal of Pharmacology and Experimental Therapeutics 2013, 347:164-172.
57. Cuzzocrea S., Nocentini G., Di Paola R., Agostini M., Mazzon E., Ronchetti S., et al. Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation. Journal of Immunology 2006, 177:631-641.
58. Cuzzocrea S., Nocentini G., Di Paola R., Mazzon E., Ronchetti S., Genovese T., et al. Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock. Journal of Leukocyte Biology 2004, 76:933-940.
59. Galuppo M., Nocentini G., Mazzon E., Ronchetti S., Esposito E., Riccardi L., et al. The glucocorticoid-induced TNF receptor family-related protein (GITR) is critical to the development of acute pancreatitis in mice. British Journal of Pharmacology 2011, 162:1186-1201.
60. Liao G., van Driel B., Magelky E., O'Keeffe M.S., de Waal Malefyt R., Engel P., et al. Glucocorticoid-induced TNF receptor family-related protein ligand regulates the migration of monocytes to the inflamed intestine. FASEB Journal: official publication of the Federation of American Societies for Experimental Biology 2013.
61. Shin H.H., Kim S.J., Lee H.S., Choi H.S. The soluble glucocorticoid-induced tumor necrosis factor receptor causes cell cycle arrest and apoptosis in murine macrophages. Biochemical and Biophysical Research Communications 2004, 316:24-32.
62. Kamimura Y., Iwai H., Piao J., Hashiguchi M., Azuma M. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity. Journal of Immunology 2009, 182:2708-2716.
63. Byrne A.M., Goleva E., Leung D.Y. Identification of glucocorticoid-induced TNF receptor-related protein ligand on keratinocytes: ligation by GITR induces keratinocyte chemokine production and augments T-cell proliferation. Journal of Investigative Dermatology 2009, 129:2784-2794.
64. Byrne A.M., Goleva E., Chouiali F., Kaplan M.H., Hamid Q.A., Leung D.Y. Induction of GITRL expression in human keratinocytes by Th2 cytokines and TNF-alpha: implications for atopic dermatitis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2012, 42:550-559.
65. Lee H.S., Park S.Y., Lee H.W., Choi H.S. Secretions of MMP-9 by soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) mediated by protein kinase C (PKC)delta and phospholipase D (PLD) in murine macrophage. Journal of Cellular Biochemistry 2004, 92:481-490.
66. Grohmann U., Volpi C., Fallarino F., Bozza S., Bianchi R., Vacca C., et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nature Medicine 2007, 13:579-586.
67. Puccetti P., Fallarino F. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells, Molecules & Diseases 2008, 40:101-105.
68. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunology 2002, 3:1097-1101.
69. Ronchetti S., Nocentini G., Petrillo M.G., Bianchini R., Sportoletti P., Bastianelli A., et al. Glucocorticoid-induced TNFR family related gene (GITR) enhances dendritic cell activity. Immunology Letters 2011, 135:24-33.
70. Hanabuchi S., Watanabe N., Wang Y.H., Wang Y.H., Ito T., Shaw J., et al. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 2006, 107:3617-3623.
71. Liu B., Li Z., Mahesh S.P., Pantanelli S., Hwang F.S., Siu W.O., et al. Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis. Journal of Biological Chemistry 2008, 283:8202-8210.
72. Baltz K.M., Krusch M., Baessler T., Schmiedel B.J., Bringmann A., Brossart P., et al. Neutralization of tumor-derived soluble glucocorticoid-induced TNFR-related protein ligand increases NK cell anti-tumor reactivity. Blood 2008, 112:3735-3743.
73. Kim H.J., Kim H.Y., Kim B.K., Kim S., Chung D.H. Engagement of glucocorticoid-induced TNF receptor costimulates NKT cell activation in vitro and in vivo. Journal of Immunology 2006, 176:3507-3515.
74. Chen S., Ndhlovu L.C., Takahashi T., Takeda K., Ikarashi Y., Kikuchi T., et al. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells. European Journal of Immunology 2008, 38:2229-2240.
75. Teodorovic L.S., Riccardi C., Torres R.M., Pelanda R. Murine B cell development and antibody responses to model antigens are not impaired in the absence of the TNF receptor GITR. PLOS ONE 2012, 7:e31632.
76. Satoguina J.S., Adjobimey T., Arndts K., Hoch J., Oldenburg J., Layland L.E., et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. European Journal of Immunology 2008, 38:3101-3113.
77. Kanamaru F., Youngnak P., Hashiguchi M., Nishioka T., Takahashi T., Sakaguchi S., et al. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. Journal of Immunology 2004, 172:7306-7314.
78. Igarashi H., Cao Y., Iwai H., Piao J., Kamimura Y., Hashiguchi M., et al. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells. Biochemical and Biophysical Research Communications 2008, 369:1134-1138.
79. Zhou P., L'Italien L., Hodges D., Schebye X.M. Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors. Journal of Immunology 2007, 179:7365-7375.
80. Zhou P., Qiu J., L'Italien L., Gu D., Hodges D., Chao C.C., et al. Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody. Journal of Immunotherapy (Hagerstown, MD: 1997) 2010, 33:789-797.
81. Ponte J.F., Ponath P., Gulati R., Slavonic M., Paglia M., O'Shea A., et al. Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody. Immunology 2010, 130:231-242.
82. Kohm A.P., Williams J.S., Miller S.D. Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis. Journal of Immunology 2004, 172:4686-4690.
83. Ronchetti S., Zollo O., Bruscoli S., Agostini M., Bianchini R., Nocentini G., et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. European Journal of Immunology 2004, 34:613-622.
84. Ronchetti S., Nocentini G., Bianchini R., Krausz L.T., Migliorati G., Riccardi C. Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells. Journal of Immunology 2007, 179:5916-5926.
85. Muriglan S.J., Ramirez-Montagut T., Alpdogan O., Van Huystee T.W., Eng J.M., Hubbard V.M., et al. GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease. Journal of Experimental Medicine 2004, 200:149-157.
86. Cho J.S., Hsu J.V., Morrison S.L. Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity. Cancer Immunology, Immunotherapy: CII 2009, 58:1057-1069.
87. Ji H.B., Liao G., Faubion W.A., Abadia-Molina A.C., Cozzo C., Laroux F.S., et al. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. Journal of Immunology 2004, 172:5823-5827.
88. Liao G., Nayak S., Regueiro J.R., Berger S.B., Detre C., Romero X., et al. GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. International Immunology 2010, 22:259-270.
89. Shevach E.M., Stephens G.L. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity. Nature Reviews Immunology 2006, 6:613-618.
90. Lin G.H., Snell L.M., Wortzman M.E., Clouthier D.L., Watts T.H. GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology. Journal of Immunology 2013, 190:4627-4639.
91. Cardona I.D., Goleva E., Ou L.S., Leung D.Y. Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. Journal of Allergy and Clinical Immunology 2006, 117:688-695.
92. Levings M.K., Sangregorio R., Sartirana C., Moschin A.L., Battaglia M., Orban P.C., et al. Human CD25+CD4+T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. Journal of Experimental Medicine 2002, 196:1335-1346.
93. Tuyaerts S., Van Meirvenne S., Bonehill A., Heirman C., Corthals J., Waldmann H., et al. Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cells. Journal of Leukocyte Biology 2007, 82:93-105.
94. Lahey T.P., Loisel S.D., Wieland-Alter W. Glucocorticoid-induced tumor necrosis factor receptor family-related protein triggering enhances HIV-specific CD4+ T cell cytokine secretion and protects HIV-specific CD4+ T cells from apoptosis. Journal of Infectious Diseases 2007, 196:43-49.
95. Stone G.W., Barzee S., Snarsky V., Spina C.A., Lifson J.D., Pillai V.K., et al. Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitro. Clinical and Vaccine Immunology: CVI 2006, 13:1223-1230.
96. Goncalves-Sousa N., Ribot J.C., deBarros A., Correia D.V., Caramalho I., Silva-Santos B. Inhibition of murine gammadelta lymphocyte expansion and effector function by regulatory alphabeta T cells is cell-contact-dependent and sensitive to GITR modulation. European Journal of Immunology 2010, 40:61-70.
97. Turk M.J., Guevara-Patino J.A., Rizzuto G.A., Engelhorn M.E., Sakaguchi S., Houghton A.N. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. Journal of Experimental Medicine 2004, 200:771-782.
98. Ko K., Yamazaki S., Nakamura K., Nishioka T., Hirota K., Yamaguchi T., et al. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. Journal of Experimental Medicine 2005, 202:885-891.
99. Hu P., Arias R.S., Sadun R.E., Nien Y.C., Zhang N., Sabzevari H., et al. Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer. Clinical Cancer Research: an official journal of the American Association for Cancer Research 2008, 14:579-588.
100. Piao J., Kamimura Y., Iwai H., Cao Y., Kikuchi K., Hashiguchi M., et al. Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours. Immunology 2009, 127:489-499.
101. Calmels B., Paul S., Futin N., Ledoux C., Stoeckel F., Acres B. Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L. Cancer Gene Therapy 2005, 12:198-205.
102. Tian J., Ma J., Ma K., Ma B., Tang X., Baidoo S.E., et al. Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma. PLOS ONE 2012, 7:e46936.
103. Nishioka T., Nishida E., Iida R., Morita A., Shimizu J. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules. Immunology Letters 2008, 121:97-104.
104. Boczkowski D., Lee J., Pruitt S., Nair S. Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy. Cancer Gene Therapy 2009, 16:900-911.
105. Nishikawa H., Kato T., Hirayama M., Orito Y., Sato E., Harada N., et al. Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling. Cancer Research 2008, 68:5948-5954.
106. Mitsui J., Nishikawa H., Muraoka D., Wang L., Noguchi T., Sato E., et al. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals. Clinical Cancer Research: an official journal of the American Association for Cancer Research 2010, 16:2781-2791.
107. Pruitt S.K., Boczkowski D., de Rosa N., Haley N.R., Morse M.A., Tyler D.S., et al. Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells. European Journal of Immunology 2011.
108. Cohen A.D., Schaer D.A., Liu C., Li Y., Hirschhorn-Cymmerman D., Kim S.C., et al. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation. PLoS ONE 2010, 5:e10436.
109. Ramirez-Montagut T., Chow A., Hirschhorn-Cymerman D., Terwey T.H., Kochman A.A., Lu S., et al. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity. Journal of Immunology 2006, 176:6434-6442.
110. Imai N., Ikeda H., Tawara I., Wang L., Wang L., Nishikawa H., et al. Glucocorticoid-induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen-specific CD8+ T cells with tumor regression. Cancer Science 2009, 100:1317-1325.
111. Liu Z., Tian S., Falo L.D., Sakaguchi S., You Z. Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligation. Molecular Therapy: the journal of the American Society of Gene Therapy 2009, 17:1274-1281.
112. Cohen A.D., Diab A., Perales M.A., Wolchok J.D., Rizzuto G., Merghoub T., et al. Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity. Cancer Research 2006, 66:4904-4912.
113. Coe D., Begom S., Addey C., White M., Dyson J., Chai J.G. Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy. Cancer Immunology, Immunotherapy: CII 2010, 59:1367-1377.
114. Cote A.L., Zhang P., O'Sullivan J.A., Jacobs V.L., Clemis C.R., Sakaguchi S., et al. Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens. Journal of Immunology 2011, 186:275-283.
115. Placke T., Kopp H.G., Salih H.R. Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation. Clinical & Developmental Immunology 2010, 239083.
116. Baltz K.M., Krusch M., Bringmann A., Brossart P., Mayer F., Kloss M., et al. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions. FASEB Journal: official publication of the Federation of American Societies for Experimental Biology 2007, 21:2442-2454.
117. Buechele C., Baessler T., Wirths S., Schmohl J.U., Schmiedel B.J., Salih H.R. Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL). Leukemia 2012, 26:991-1000.
118. Baessler T., Krusch M., Schmiedel B.J., Kloss M., Baltz K.M., Wacker A., et al. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans. Cancer Research 2009, 69:1037-1045.
119. Placke T., Salih H.R., Kopp H.G. GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity. Journal of Immunology 2012, 189:154-160.
120. Liu Y., Quang P., Braggio E., Ngo H., Badalian-Very G., Flores L., et al. Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma. PLOS ONE 2013, 8:e66982.
121. Nocentini G., Cuzzocrea S., Bianchini R., Mazzon E., Riccardi C. Modulation of acute and chronic inflammation of the lung by GITR and its ligand. Annals of the New York Academy of Sciences 2007, 1107:380-391.
122. Cuzzocrea S., Ayroldi E., Di Paola R., Agostini M., Mazzon E., Bruscoli S., et al. Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis. FASEB Journal: official publication of the Federation of American Societies for Experimental Biology 2005, 19:1253-1265.
123. Cuzzocrea S., Ronchetti S., Genovese T., Mazzon E., Agostini M., Di Paola R., et al. Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation. FASEB Journal: official publication of the Federation of American Societies for Experimental Biology 2007, 21:117-129.
124. Galuppo M., Nocentini G., Mazzon E., Ronchetti S., Esposito E., Riccardi L., et al. GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan. Shock (Augusta, GA) 2011, 36:263-271.
125. Nocentini G., Cuzzocrea S., Genovese T., Bianchini R., Mazzon E., Ronchetti S., et al. Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury. Molecular Pharmacology 2008, 73:1610-1621.
126. Santucci L., Agostini M., Bruscoli S., Mencarelli A., Ronchetti S., Ayroldi E., et al. GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut 2007, 56:52-60.
127. Takata M., Nakagomi T., Kashiwamura S., Nakano-Doi A., Saino O., Nakagomi N., et al. Glucocorticoid-induced TNF receptor-triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke. Cell Death and Differentiation 2012, 19:756-767.
128. Shin H.H., Kim S.G., Lee M.H., Suh J.H., Kwon B.S., Choi H.S. Soluble glucocorticoid-induced TNF receptor (sGITR) induces inflammation in mice. Experimental & Molecular Medicine 2003, 35:358-364.
129. Tamayo E., Postigo J., Gonzalez J., Fernandez-Rey M., Iglesias M., Santiuste I., et al. GITR contributes to the systemic adjuvanticity of the Escherichia coli heat-labile enterotoxin. European Journal of Immunology 2010, 40:754-763.
130. Scumpia P.O., Delano M.J., Kelly-Scumpia K.M., Weinstein J.S., Wynn J.L., Winfield R.D., et al. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood 2007, 110:3673-3681.
131. Motta A.C., Vissers J.L., Gras R., Van Esch B.C., Van Oosterhout A.J., Nawijn M.C. GITR signaling potentiates airway hyperresponsiveness by enhancing Th2 cell activity in a mouse model of asthma. Respiratory Research 2009, 10:93.
132. Joetham A., Matsubara S., Okamoto M., Takeda K., Miyahara N., Dakhama A., et al. Plasticity of regulatory T cells: subversion of suppressive function and conversion to enhancement of lung allergic responses. Journal of Immunology 2008, 180:7117-7124.
133. Albrecht M., Arnhold M., Lingner S., Mahapatra S., Bruder D., Hansen G., et al. IL-4 attenuates pulmonary epithelial cell-mediated suppression of T cell priming. PLOS ONE 2012, 7:e45916.
134. Singh B., Read S., Asseman C., Malmstrom V., Mottet C., Stephens L.A., et al. Control of intestinal inflammation by regulatory T cells. Immunological Reviews 2001, 182:190-200.
135. Uraushihara K., Kanai T., Ko K., Totsuka T., Makita S., Iiyama R., et al. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. Journal of Immunology 2003, 171:708-716.
136. Lee S.K., Choi B.K., Kim Y.H., Kang W.J., Kim K.H., Sakaguchi S., et al. Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells. Immunology 2006, 119:479-487.
137. Morris G.P., Kong Y.C. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. Journal of Autoimmunity 2006, 26:24-31.
138. Ephrem A., Epstein A.L., Stephens G.L., Thornton A.M., Glass D., Shevach E.M. Modulation of Treg cells/T effector function by GITR signaling is context-dependent. European Journal of Immunology 2013, 43:2421-2429.
139. Kim S.H., Youn J. Rheumatoid fibroblast-like synoviocytes downregulate foxp3 expression by regulatory T cells Via GITRL/GITR interaction. Immune Network 2012, 12:217-221.
140. Carrier Y., Whitters M.J., Miyashiro J.S., LaBranche T.P., Ramon H.E., Benoit S.E., et al. Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells. European Journal of Immunology 2012, 42:1393-1404.
141. van Olffen R.W., Koning N., van Gisbergen K.P., Wensveen F.M., Hoek R.M., Boon L., et al. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. Journal of Immunology 2009, 182:7490-7500.
142. Ray A., Basu S., Williams C.B., Salzman N.H., Dittel B.N. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. Journal of Immunology 2012, 188:3188-3198.
143. Patel M., Xu D., Kewin P., Choo-Kang B., McSharry C., Thomson N.C., et al. Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis. European Journal of Immunology 2005, 35:3581-3590.
144. You S., Poulton L., Cobbold S., Liu C.P., Rosenzweig M., Ringler D., et al. Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target. PLoS ONE 2009, 4:e7848.
145. Couper K.N., Blount D.G., de Souza J.B., Suffia I., Belkaid Y., Riley E.M. Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. Journal of Immunology 2007, 178:4136-4146.
146. Liao G., Detre C., Berger S.B., Engel P., de Waal Malefyt R., Herzog R.W., et al. Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice. Gastroenterology 2012, 142:582-591. e8.
147. Bushell A., Wood K. GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function. American Journal of Transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007, 7:759-768.
148. Sonawane S.B., Kim J.I., Lee M.K., Lee S.H., Duff P.E., Moore D.J., et al. GITR blockade facilitates Treg mediated allograft survival. Transplantation 2009, 88:1169-1177.
149. Kim J.I., Sonawane S.B., Lee M.K., Lee S.H., Duff P.E., Moore D.J., et al. Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival. European Journal of Immunology 2010, 40:1369-1374.
150. Krill K.T., Csencsits-Smith K., Wood S.C., Faust S., Lu G., Bishop D.K. Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade. Clinical & Developmental Immunology 2013, 2013:986859.
151. Mahesh S.P., Li Z., Liu B., Fariss R.N., Nussenblatt R.B. Expression of GITR ligand abrogates immunosuppressive function of ocular tissue and differentially modulates inflammatory cytokines and chemokines. European Journal of Immunology 2006, 36:2128-2138.
152. Kim B.J., Li Z., Fariss R.N., Shen D.F., Mahesh S.P., Egwuagu C., et al. Constitutive and cytokine-induced GITR ligand expression on human retinal pigment epithelium and photoreceptors. Investigative Ophthalmology & Visual Science 2004, 45:3170-3176.
153. Hori J., Taniguchi H., Wang M., Oshima M., Azuma M. GITR ligand-mediated local expansion of regulatory T cells and immune privilege of corneal allografts. Investigative Ophthalmology & Visual Science 2010, 51:6556-6565.
154. Valzasina B., Guiducci C., Dislich H., Killeen N., Weinberg A.D., Colombo M.P. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 2005, 105:2845-2851.
155. Kim J., Park K., Kim H.J., Kim J., Kim H.A., Jung D., et al. Breaking of CD8+ T cell tolerance through in vivo ligation of CD40 results in inhibition of chronic graft-versus-host disease and complete donor cell engraftment. Journal of Immunology 2008, 181:7380-7389.
156. Kim J., Choi W.S., Kang H., Kim H.J., Suh J.H., Sakaguchi S., et al. Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor. Journal of Immunology 2006, 176:5223-5231.
157. Tomizawa R., Watanabe M., Inoue N., Takemura K., Hidaka Y., Akamizu T., et al. Association of functional GITR gene polymorphisms related to expression of glucocorticoid-induced tumour necrosis factor-receptor (GITR) molecules with prognosis of autoimmune thyroid disease. Clinical and Experimental Immunology 2011, 165:141-147.
158. Li Z., Mahesh S.P., Kim B.J., Buggage R.R., Nussenblatt R.B. Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. Journal of Autoimmunity 2003, 21:83-92.
159. Gan X., Feng X., Gu L., Tan W., Sun X., Lv C., et al. Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sjogren's syndrome. Clinical & Developmental Immunology 2013, 2013:340751.
160. Gu L., Xu L., Zhang X., Tan W., Wang H., Zhang M. Correlation of circulating glucocorticoid-induced TNFR-related protein ligand levels with disease activity in patients with systemic lupus erythematosus. Clinical & Developmental Immunology 2012, 2012:265868.
161. Wang S., Shi Y., Yang M., Ma J., Tian J., Chen J., et al. Glucocorticoid-induced tumor necrosis factor receptor family-related protein exacerbates collagen-induced arthritis by enhancing the expansion of Th17 cells. American Journal of Pathology 2012, 180:1059-1067.
162. Furze R.C., Culley F.J., Selkirk M.E. Differential roles of the co-stimulatory molecules GITR and CTLA-4 in the immune response to Trichinella spiralis. Microbes and Infection/Institut Pasteur 2006, 8:2803-2810.
163. van der Werf N., Redpath S.A., Phythian-Adams A.T., Azuma M., Allen J.E., Maizels R.M., et al. Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITR ligand costimulation in vivo. Journal of Immunology 2011, 187:1411-1420.
164. Haque A., Stanley A.C., Amante F.H., Rivera Fde L., Zhou Y., Kuns R.D., et al. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity. Journal of Immunology 2010, 184:2583-2592.
165. Agostini M., Cenci E., Pericolini E., Nocentini G., Bistoni G., Vecchiarelli A., et al. The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection. Infection and Immunity 2005, 73:7502-7508.
166. Vecchiarelli A., Pericolini E., Gabrielli E., Agostini M., Bistoni F., Nocentini G., et al. The GITRL-GITR system alters TLR-4 expression on DC during fungal infection. Cellular Immunology 2009, 257:13-22.
167. La S., Kim E., Kwon B. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Experimental & Molecular Medicine 2005, 37:193-198.
168. He H., Messer R.J., Sakaguchi S., Yang G., Robertson S.J., Hasenkrug K.J. Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection. Journal of Virology 2004, 78:11641-11647.
169. Dittmer U., He H., Messer R.J., Schimmer S., Olbrich A.R., Ohlen C., et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004, 20:293-303.
170. Ronchetti S., Nocentini G., Petrillo M.G., Riccardi C.C.D8+ T cells: GITR matters. Scientific World Journal 2012, 2012:308265.
171. Dittmer U., Werner T., Kraft A.R. Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection. Viral Immunology 2008, 21:459-467.
172. Hoffmann C., Stanke J., Kaufmann A.M., Loddenkemper C., Schneider A., Cichon G. Combining T-cell vaccination and application of agonistic anti-GITR mAb (DTA-1) induces complete eradication of HPV oncogene expressing tumors in mice. Journal of Immunotherapy (Hagerstown, MD: 1997) 2010, 33:136-145.
173. Nocentini G., Riccardi C. GITR: a modulator of immune response and inflammation. Advances in Experimental Medicine and Biology 2009, 647:156-173.
174. Kang N., Tang L., Li X., Wu D., Li W., Chen X., et al. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Immunology Letters 2009, 125:105-113.